Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials

Background Use of the modified American College of Cardiology (ACC)/American Heart Association (AHA) lesion classification as a prognostic tool to predict short‐ and long‐term clinical outcomes after percutaneous coronary intervention in the modern drug‐eluting stent era is uncertain. Methods and Re...

Full description

Bibliographic Details
Main Authors: Maayan Konigstein, Björn Redfors, Zixuan Zhang, Lak N. Kotinkaduwa, Gary S. Mintz, Pieter C. Smits, Patrick W. Serruys, Clemens von Birgelen, Mahesh V. Madhavan, Mordechai Golomb, Ori Ben‐Yehuda, Roxana Mehran, Martin B. Leon, Gregg W. Stone
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.025275
_version_ 1811170031625568256
author Maayan Konigstein
Björn Redfors
Zixuan Zhang
Lak N. Kotinkaduwa
Gary S. Mintz
Pieter C. Smits
Patrick W. Serruys
Clemens von Birgelen
Mahesh V. Madhavan
Mordechai Golomb
Ori Ben‐Yehuda
Roxana Mehran
Martin B. Leon
Gregg W. Stone
author_facet Maayan Konigstein
Björn Redfors
Zixuan Zhang
Lak N. Kotinkaduwa
Gary S. Mintz
Pieter C. Smits
Patrick W. Serruys
Clemens von Birgelen
Mahesh V. Madhavan
Mordechai Golomb
Ori Ben‐Yehuda
Roxana Mehran
Martin B. Leon
Gregg W. Stone
author_sort Maayan Konigstein
collection DOAJ
description Background Use of the modified American College of Cardiology (ACC)/American Heart Association (AHA) lesion classification as a prognostic tool to predict short‐ and long‐term clinical outcomes after percutaneous coronary intervention in the modern drug‐eluting stent era is uncertain. Methods and Results Patient‐level data from 7 prospective, randomized trials were pooled. Clinical outcomes of patients undergoing single lesion percutaneous coronary intervention with second‐generation drug‐eluting stent were analyzed according to modified ACC/AHA lesion class. The primary end point was target lesion failure (TLF: composite of cardiac death, target vessel myocardial infarction, or ischemia‐driven target lesion revascularization). Clinical outcomes to 5 years were compared between patients treated for noncomplex (class A/B1) versus complex (class B2/C) lesions. Eight thousand five hundred sixteen patients (age 63.1±10.8 years, 70.5% male) were analyzed. Lesions were classified as A, B1, B2, and C in 7.9%, 28.5%, 33.7%, and 30.0% of cases, respectively. Target lesion failure was higher in patients undergoing percutaneous coronary intervention of complex versus noncomplex lesions at 30 days (2.0% versus 1.1%, P=0.004), at 1 year (4.6% versus 3.0%, P=0.0005), and at 5 years (12.4% versus 9.2%, P=0.0001). By multivariable analysis, treatment of ACC/AHA class B2/C lesions was significantly associated with higher rate of 5‐year target lesion failure (adjusted hazard ratio, 1.39 [95% CI, 1.17–1.64], P=0.0001) driven by significantly higher rates of target vessel myocardial infarction and ischemia‐driven target lesion revascularization. Conclusions In this pooled large‐scale analysis, treating complex compared with noncomplex lesions according to the modified ACC/AHA classification with second‐generation drug‐eluting stent was associated with worse 5‐year clinical outcomes. This historical classification system may be useful in the contemporary era for predicting early and late outcomes following percutaneous coronary intervention.
first_indexed 2024-04-10T16:50:47Z
format Article
id doaj.art-51dbe898fe084a8ea656381d9bc2242c
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-10T16:50:47Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-51dbe898fe084a8ea656381d9bc2242c2023-02-07T16:03:49ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-12-01112410.1161/JAHA.121.025275Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized TrialsMaayan Konigstein0Björn Redfors1Zixuan Zhang2Lak N. Kotinkaduwa3Gary S. Mintz4Pieter C. Smits5Patrick W. Serruys6Clemens von Birgelen7Mahesh V. Madhavan8Mordechai Golomb9Ori Ben‐Yehuda10Roxana Mehran11Martin B. Leon12Gregg W. Stone13Clinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYMaasstad Ziekenhuis Rotterdam The NetherlandsImperial College of Science, Technology and Medicine London United KingdomDepartment of Cardiology Thoraxcentrum Twente, Medisch Spectrum Twente Enschede The NetherlandsClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYUniversity of California ‐ San Diego Health – La Jolla and Hillcrest Hospitals San Diego CABackground Use of the modified American College of Cardiology (ACC)/American Heart Association (AHA) lesion classification as a prognostic tool to predict short‐ and long‐term clinical outcomes after percutaneous coronary intervention in the modern drug‐eluting stent era is uncertain. Methods and Results Patient‐level data from 7 prospective, randomized trials were pooled. Clinical outcomes of patients undergoing single lesion percutaneous coronary intervention with second‐generation drug‐eluting stent were analyzed according to modified ACC/AHA lesion class. The primary end point was target lesion failure (TLF: composite of cardiac death, target vessel myocardial infarction, or ischemia‐driven target lesion revascularization). Clinical outcomes to 5 years were compared between patients treated for noncomplex (class A/B1) versus complex (class B2/C) lesions. Eight thousand five hundred sixteen patients (age 63.1±10.8 years, 70.5% male) were analyzed. Lesions were classified as A, B1, B2, and C in 7.9%, 28.5%, 33.7%, and 30.0% of cases, respectively. Target lesion failure was higher in patients undergoing percutaneous coronary intervention of complex versus noncomplex lesions at 30 days (2.0% versus 1.1%, P=0.004), at 1 year (4.6% versus 3.0%, P=0.0005), and at 5 years (12.4% versus 9.2%, P=0.0001). By multivariable analysis, treatment of ACC/AHA class B2/C lesions was significantly associated with higher rate of 5‐year target lesion failure (adjusted hazard ratio, 1.39 [95% CI, 1.17–1.64], P=0.0001) driven by significantly higher rates of target vessel myocardial infarction and ischemia‐driven target lesion revascularization. Conclusions In this pooled large‐scale analysis, treating complex compared with noncomplex lesions according to the modified ACC/AHA classification with second‐generation drug‐eluting stent was associated with worse 5‐year clinical outcomes. This historical classification system may be useful in the contemporary era for predicting early and late outcomes following percutaneous coronary intervention.https://www.ahajournals.org/doi/10.1161/JAHA.121.025275drug‐eluting stentspercutaneous coronary interventiontarget lesion failure
spellingShingle Maayan Konigstein
Björn Redfors
Zixuan Zhang
Lak N. Kotinkaduwa
Gary S. Mintz
Pieter C. Smits
Patrick W. Serruys
Clemens von Birgelen
Mahesh V. Madhavan
Mordechai Golomb
Ori Ben‐Yehuda
Roxana Mehran
Martin B. Leon
Gregg W. Stone
Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
drug‐eluting stents
percutaneous coronary intervention
target lesion failure
title Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials
title_full Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials
title_fullStr Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials
title_full_unstemmed Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials
title_short Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials
title_sort utility of the acc aha lesion classification to predict outcomes after contemporary des treatment individual patient data pooled analysis from 7 randomized trials
topic drug‐eluting stents
percutaneous coronary intervention
target lesion failure
url https://www.ahajournals.org/doi/10.1161/JAHA.121.025275
work_keys_str_mv AT maayankonigstein utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT bjornredfors utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT zixuanzhang utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT laknkotinkaduwa utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT garysmintz utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT pietercsmits utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT patrickwserruys utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT clemensvonbirgelen utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT maheshvmadhavan utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT mordechaigolomb utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT oribenyehuda utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT roxanamehran utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT martinbleon utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials
AT greggwstone utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials